Vertis Capital Partners Acquires Stake in DunPort to Boost European Credit Growth DunPort Capital Management announces a strategic partnership with Vertis Capital Partners to enhance private credit expansion across Europe.

Vertis Capital Partners Acquires Stake in DunPort to Boost European Credit Growth #London #United_Kingdom #DunPort #Vertis #Henry_Costa

Vertis Capital Partners Teams Up with DunPort for European Private Credit Growth Discover the strategic partnership between Vertis and DunPort aimed at expanding private credit solutions across Europe, enhancing institutional fundraising efforts.

Vertis Capital Partners Teams Up with DunPort for European Private Credit Growth #London #United_Kingdom #private_credit #DunPort #Vertis

Instagram (@suman.behera) Instagram photos and videos

Let's get those #SGLT2i (inhibitors) onboard for #DiabeticKidneyDisease regardless of #albuminuria
#kireports Heart & Kidney outcomes w/ #Ertugliflozin in non-albuminuric diabetic kidney disease: post hoc Analysis from Randomized #VERTIS CV trial

instagram.com/stories/suman.…

Instagram (@suman.behera) Instagram photos and videos

Let's get those #SGLT2i (inhibitors) onboard for #DiabeticKidneyDisease regardless of #albuminuria
#kireports Heart & Kidney outcomes w/ #Ertugliflozin in non-albuminuric diabetic kidney disease: post hoc Analysis from Randomized #VERTIS CV trial

instagram.com/stories/suman.…

Let's get those #SGLT2i (inhibitors) onboard for #DiabeticKidneyDisease regardless of #albuminuria
#kireports Heart & Kidney outcomes w/ #Ertugliflozin in non-albuminuric diabetic kidney disease: post hoc Analysis from Randomized #VERTIS CV trial
Visual abstract-@md_abdulqader83

Let's get those #SGLT2i (inhibitors) onboard for #DiabeticKidneyDisease regardless of #albuminuria
#kireports Heart & Kidney outcomes w/ #Ertugliflozin in non-albuminuric diabetic kidney disease: post hoc Analysis from Randomized #VERTIS CV trial
Visual abstract-@md_abdulqader83